You are here

News

Jan
30
2018

Molecular Matrix Welcomes Steve Whitlock to Management Team

SACRAMENTO, CA – January 30, 2018 – Molecular Matrix, Inc (MMI), a biotechnology company developing an innovative tissue regeneration technology for orthopedic applications, today announced the appointment of Steve Whitlock as Chief Commercial Officer.

Steve has over 25 years of orthopedics industry experience and comes to MMI from Spindletop Capital of Austin, TX, a healthcare investment firm focused on providing expansion capital for commercial stage healthcare companies, where he was Managing Director for the past four years.

Nov
7
2016

We Moved!

Molecular Matrix, Inc. is now located in West Sacramento. 

3410 Industrial Blvd. Suite 103 West Sacramento, CA 95691

Jun
18
2014

Product Launch in Vancouver

Molecular Matrix, Inc. launches their GroCell-3D™ product portfolio at the International Society for Stem Cell Research (ISSCR) in Vancouver.

May
1
2014

Multiple Cell Types Confirmed

Molecular Matrix, Inc. confirms their GroCell-3D™ scaffold supports multiple cell types to include Osteocytes, ESCs, MSCs, Hepatocytes, Kidney Tumor Cells, Co-Cultures, and Endothelial cells.

Apr
1
2014

Dynamic Culture System Completed

Molecular Matrix, Inc. completes design and testing of their dynamic culture system. Internal tests verify the effectiveness of the system showing cells grown on the 3D scaffold in the dynamic culture system proliferate exponentially compared to a static culture system.

Oct
1
2013

Moving to Davis

Molecular Matrix, Inc. moves from Berkeley to a new office in Davis.

2062 John Jones Road Suite 100 Davis, CA

Pages